Bristol-Myers Squibb Co (NYSE:BMY)
| 77.05 BATS BZX Real-Time Price As of 10:31am ET |  +1.09 / +1.43%Today’s Change | 53.22 Today|||52-Week Range 80.59 | +23.58% Year-to-Date |
Latest BMY News | Press Releases
Today’s Trading
| Previous close | 75.96 |
| Today’s open | 76.12 |
| Day’s range | 76.12 - 77.05 |
| Volume | 1,198,014 |
| Average volume (3 months) | 14,937,479 |
| Market cap | $163.6B |
Data as of 10:31am ET, 07/06/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +0.66% |
| Earnings growth (next 5 years) | +5.23% |
| Revenue growth (last year) | +9.09% |
| P/E ratio | 27.2 |
| Price/Sales | 3.02 |
| Price/Book | 4.65 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | -0.35 | -0.42% |
| NVONovo Nordisk | -0.92 | -0.83% |
| SNYSanofi | -0.13 | -0.26% |
| AZNAstraZeneca | +0.66 | +1.01% |
Data as of 10:31am ET, 07/06/2022
Financials
| Next reporting date | July 27, 2022 |
| EPS forecast (this quarter) | $1.88 |
| Annual revenue (last year) | $46.4B |
| Annual profit (last year) | $7.0B |
| Net profit margin | 15.08% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
